{
    "clinical_study": {
        "@rank": "99152", 
        "acronym": "SEAL", 
        "arm_group": {
            "arm_group_label": "Inpatients", 
            "description": "Participants who had lymph node resection."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to describe effectiveness and reliability of TachoSil\u00ae  in\n      lymph sealing after lymphadenectomy."
        }, 
        "brief_title": "Use of Tachosil\u00ae for Lymph Sealing During Surgery", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Lymph Node Resection", 
        "detailed_description": {
            "textblock": "The aim of this non-interventional study (NIS) is to collect further knowledge on the\n      routine use of TachoSil \u00ae in lymph node surgery where its sealing property helps to reduce\n      the rate of postoperative complications, especially of seroma formation. Some data are\n      already available from gynecology, urology and thoracic surgery."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Stationary patients undergoing lymph node resection.\n\n        Exclusion Criteria:\n\n          -  Contraindications, such as hypersensitivity to the active pharmaceutical ingredient\n             or to another ingredient."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Stationary patients in whom a lymph node resection is planned to be performed"
            }
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01920958", 
            "org_study_id": "TC-2402-401-DE", 
            "secondary_id": "U1111-1142-0279"
        }, 
        "intervention": {
            "arm_group_label": "Inpatients", 
            "description": "TachoSil\u00ae is a collagen sponge that is coated with the active substances human fibrinogen and human thrombin and that supports hemostasis and sealing of surgical wound.", 
            "intervention_name": "TachoSil\u00ae", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 8, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Greifswald", 
                    "country": "Germany"
                }
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Use of Tachosil\u00ae for Lymph Sealing During Surgery. A Non-Interventional Study", 
        "overall_contact": {
            "email": "medicalinformation@tpna.com", 
            "last_name": "Takeda Study Registration Call Center", 
            "phone": "1-800-778-2860"
        }, 
        "overall_official": {
            "affiliation": "Takeda Pharma Vertrieb GmbH & Co. KG", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Paul-Ehrlich-Institut,Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Incidence of post-operative seroma formation over time as determined at hospital discharge", 
            "safety_issue": "Yes", 
            "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01920958"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Assessment of TachoSil\u00ae by the surgeon with respect to handling, utility and satisfaction in the operation, documented using 10 point Numerical Rating Scales", 
                "safety_issue": "No", 
                "time_frame": "Peri- and post-surgery"
            }, 
            {
                "measure": "Usage, duration and volume of drainage", 
                "safety_issue": "No", 
                "time_frame": "Peri- and post-surgery until hospital discharge"
            }, 
            {
                "description": "Length of stay includes time spent in the intensive care unit (ICU) and normal hospital station.", 
                "measure": "Length of hospital stay", 
                "safety_issue": "No", 
                "time_frame": "Date of surgery until hospital discharge"
            }, 
            {
                "measure": "Pharmacoeconomic evaluation as assessed by the surgeon at hospital discharge based on savings of OP- time (minutes), shortening of hospital stay (days), reduction of drainage time (days) and drainage volume (ml)", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 30 days"
            }, 
            {
                "measure": "Number of participants with intra- and post-operative complications and adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "Peri-surgery to 30 days post-surgery"
            }
        ], 
        "source": "Takeda", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Takeda", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2013"
    }
}